clinical trials OHC
At OHC, our search for new treatments is relentless. Our nationally recognized clinical trials team is engaged in a passionate search for innovative treatments so patients can access promising new cancer treatments that may benefit them right now. 

OHC is one of only six community oncology practices in the nation that has been recognized by the Conquer Cancer Foundation of the American Society of Clinical Oncology for its commitment to a high-quality clinical trials program. OHC is an American Society of Clinical Oncology Clinical Trial Award winner for its dedication to conquering cancer worldwide by funding breakthrough cancer research and providing treatments to the communities we serve. 

OHC is an established research leader in communities across the greater Cincinnati region and offers clinical trials through the Sarah Cannon Research Institute (SCRI), one of the world’s leading oncology research organizations conducting community-based clinical trials. SCRI has contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today.

Our research program, SCRI at OHC, provides access to the latest clinical trial options for people facing cancer and is part of an expansive research network with the goals of advancing therapies for patients and transforming cancer care within the community, where the majority of people seek cancer treatment. At any given time, OHC offers clinical treatment options in various disease types including breast cancer, lung cancer, colorectal cancer, prostate cancer, gynecologic cancers, and blood cancers such as multiple myeloma, leukemia, and lymphoma.  See our full list of enrolling clinical trials.

For more information about our clinical trials options, please call 888-649-4800 or schedule an appointment.

The following OHC doctors specialize in clinical research and serve as clinical trial principal investigators: